Ken Keyong Ren Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Ken Keyong Ren.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Ken Keyong Ren. Ken Keyong Ren is a CEO and Director in CASI Pharmaceuticals, Inc. ($CASI) and an Chief Executive Officer in CASI Pharmaceuticals, Inc. ($CASI) and a Director in CASI Pharmaceuticals, Inc. ($CASI).

Address: 9640 MEDICAL CENTER DRIVE ROCKVILLE US 20850 MD

Companies in which Ken Keyong Ren is an Insider

CASI Pharmaceuticals, Inc.

Trading Symbol: CASI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ken Keyong Ren: CEO and Director, Chief Executive Officer
Holdings: 15,000 shares
Current Value: $20,850
Latest Transaction: Jun 21 2019
$CASI Market Capitalization: $81.26M
$CASI Previous Close: $1.39

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Ken Keyong Ren

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 21 2019CASICASI Pharmaceutica ...Ren Ken KeyongDirectorOption ExerciseA3.1351,538161,31451,538
Jan 31 2019CASICASI Pharmaceutica ...Ren Ken KeyongChief Executive Off ...Option ExerciseA0.8875,00066,00075,000
Dec 06 2018CASICASI Pharmaceutica ...Ren Ken KeyongChief Executive Off ...Option ExerciseA0.99720,000712,800720,000
Oct 05 2016CASICASI Pharmaceutica ...Ren Ken KeyongChief Executive Off ...Option ExerciseA1.11308,571342,514308,571
Jun 27 2016CASICASI Pharmaceutica ...Ren Ken KeyongChief Executive Off ...Option ExerciseA1.1586,48699,45986,486
Jun 03 2016CASICASI Pharmaceutica ...Ren Ken KeyongChief Executive Off ...Option ExerciseA0.86280,701241,431280,701
Mar 04 2016CASICASI Pharmaceutica ...Ren Ken KeyongChief Executive Off ...Option ExerciseA0.88125,000110,000125,000

View all Ken Keyong Ren insider transactions.

What is the IPO and How Does a Company Go Public?

IPO stands for Initial Public Offering. An IPO is done when a privately owned company wants to sell a portion of it to public investors. Through this process the company is transformed from a privately owned to a company owned by public investors. More ...

What Is a Rule 10b5-1 Plan?

Rule 10b5 is one of the most important acts put forth by the SEC. It prohibits fraud, misrepresentation, and deceit in the sale and purchase of securities on national exchanges. More ...

Are IPOs Interesting for Small Investors?

Initial Public Offering is the first sale of stock by a privately owned company to the public. Companies negotiate a sale of their stock to an investment banker or several bankers that act as an underwriter for the offering. More ...

Contact us | Follow us on Twitter